Course #125 Remimazolam

$20.00

Mark Haffey CRNA describes the pharmacokinetics and pharmacodynamics of the ultra-short acting benzodiazepine, remimazolam. He identifies select patients and off label uses of remimazolam as well as discusses the goals of pharmacologic agents in the outpatient setting. This course is valued at 1 Class A CE [pharm credit].

Category:

Description

Mark Haffey CRNA describes the pharmacokinetics and pharmacodynamics of the ultra-short acting benzodiazepine, remimazolam. He identifies select patients and off label uses of remimazolam as well as discusses the goals of pharmacologic agents in the outpatient setting. This course is valued at 1 Class A CE [pharm credit].